Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

67%

2 of 3 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT02900924Completed

Observational Study to Evaluate the BioMimics 3D Stent System: MIMICS-3D

Role: lead

NCT04640597Unknown

MIMICS-3D-USA Registry Study

Role: lead

NCT02400905Not ApplicableCompleted

Evaluation of Safety and Effectiveness of the BioMimics 3D Stent System

Role: lead

NCT02163863Not ApplicableCompleted

BioMimics 3D Stent Clinical Investigation: The Mimics Study

Role: lead

All 4 trials loaded